Clinical UpdatesDrug News

Merck & Co. plans to file five new drug applications this year but said it has ended development of its… »   

Novo Nordisk has outlined its plans to commence a new clinical trial to support the positive effect its diabetes drug… »   

Regulators, scientists at 17 companies and academic researchers have teamed up in a new international experiment to find agreed-upon ways… »   

The availability of more affordable drugs, vaccines and diagnostics that would help countless people worldwide is the foremost benefit expected… »   

Alkermes Inc. said the U.S. Food and Drug Administration will reconsider its application for a diabetes drug target whose previous… »   

CPEX Pharmaceuticals Inc (CPEX.O) said the hostile bid by one its investors to take the firm private for $16… »   

U.S. inspectors found thick dust and contaminated ingredients at the Johnson & Johnson plant that produces Children’s Tylenol and dozens… »   

The birth control pill has been called the most important scientific advance of the 20th century, and no wonder. Fifty… »   

In a move to crack down on a small population using the drugs to get high, potent codeine-based pain relievers… »   

The top-selling brand-name diabetes drug, Actos, will be available in generic form in two years under a settlement reached by… »   

Bayer’s Didget, an FDA-approved device that allows players to transmit diabetes test data to a Nintendo DS in order to… »   

Drugs currently used for the treatment of diabetes could offer a new way to manage incurable bowel conditions such as… »   

Novartis has announced that The European Commission, or EC, has granted Diovan, or valsartan, a new pediatric indication for the… »   

Alkermes is usually cast on Wall Street as a supporting actor in the eagerly-anticipated debut of the once-weekly diabetes drug… »   

Making simple changes like getting people to take their medicines exactly as directed or to refill their prescriptions on time… »